SAB Biotherapeutics, Inc.
USD0.01
-0.00 (-7.25%)
CEO
Samuel J. Reich
IPO Date
2021-10-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.01
52W High
$0.05
Market Cap
$0.00B
Volume
0.00M
| -1.0 |
| 31 Dec 2023 | FY | -67.3% | -1884.5% | -73.6% | -50.3% | 0.10 | 5.45 | -0.9 |
| 31 Dec 2022 | FY | 86.2% | -78.4% | -60.3% | -36.8% | 0.19 | 1.47 | -1.4 |
| 31 Dec 2021 | FY | 97.3% | -28.2% | -44.5% | -21.1% | 0.22 | 1.90 | -19.8 |
| 31 Dec 2020 | FY | 100.0% | 36.4% | 51.6% | 35.6% | 0.21 | 3.11 | 21.9 |
| 31 Dec 2019 | FY | 100.0% | -261.1% | 389.8% | -49.9% | -3.31 | 2.01 | -49.1 |
| -1.1 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | 27.5% | 24.8% | 0.04 | 10.50 | 0.1 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -84.2% | -33.6% | 0.53 | 0.87 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -24.3% | -13.6% | 0.32 | 1.69 | -0.6 |
| 31 Dec 2024 | Q4 | -585.0% | -9934.5% | -43.9% | -25.8% | 0.18 | 2.98 | -0.8 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -28.0% | -19.2% | 0.12 | 3.69 | -0.6 |
| 30 Jun 2024 | Q2 | -288.4% | -2787.7% | -15.9% | -11.9% | 0.12 | 5.24 | -1.0 |
| 31 Mar 2024 | Q1 | -110.1% | -532.1% | -9.5% | -7.0% | 0.10 | 5.65 | -2.0 |
| 31 Dec 2023 | Q4 | -209.5% | -7493.8% | -39.9% | -27.2% | 0.10 | 5.45 | -0.4 |